InflaRx (IFRX) Income from Continuing Operations (2016 - 2026)

InflaRx's Income from Continuing Operations history spans 9 years, with the latest figure at 8029644.51 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 38.97% to 8029644.51 in Q1 2026 year-over-year; TTM through Mar 2026 was 8984179.53, a 336.1% increase, with the full-year FY2025 number at 53119705.66, down 7.91% from a year prior.
  • Income from Continuing Operations hit 8029644.51 in Q1 2026 for InflaRx, down from 41591685.39 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for IFRX hit a ceiling of 495415943590.83 in Q1 2023 and a floor of 16617096.57 in Q1 2022.
  • Historically, Income from Continuing Operations has averaged 41392240579.81 across 5 years, with a median of 10550150.53 in 2025.
  • The widest YoY moves for Income from Continuing Operations: up 2981462.85% in 2023, down 797.68% in 2023.
  • Tracing IFRX's Income from Continuing Operations over 5 years: stood at 7543918.17 in 2022, then tumbled by 75.22% to 13218336.02 in 2023, then skyrocketed by 454.76% to 46893327.95 in 2024, then fell by 11.31% to 41591685.39 in 2025, then tumbled by 119.31% to 8029644.51 in 2026.
  • Business Quant data shows Income from Continuing Operations for IFRX at 8029644.51 in Q1 2026, 41591685.39 in Q4 2025, and 10550150.53 in Q3 2025.